Abstract

LifeArc has a 25-year legacy of collaborating with scientists, academics and industry on diagnostics and therapies, enhancing and protecting innovation, and advancing promising research. We have been enormously successful in these endeavours. But the world we deliver products into doesn’t stand still. Healthcare, science and technology are ever-changing, and this applies to translation as well. In the future, pharmaceutical companies will still need well prepared, validated therapeutic opportunities. But to be differentiated, the products will need to carry more information than they have in the past. Diagnostics will be able to identify much earlier those patients at likelihood of developing a condition. Advances in data analytics and genomic information will enable greater targeting of medicines to a sub-set of patients. How do we nurture effective translation as the world of digital informatics rapidly evolves?